Search - tctmd.com

Displaying 441 - 460 of 656

Sort: Relevancy | Date

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

Polymer-Free BioFreedom Stent as Safe as Orsiro, but Not as Effective

News Conference News TCT 2018

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

Michael O'Riordan

September 22, 2018

Presentation TCT 2018

CHIP in The Diabetic Patient: Special Considerations

Presenter: David J. Maron, Steven P. Marso, Cindy L. Grines

September 22, 2018

Presentation TCT 2018

Complete Revascularization is the Missing Link to Improve Diabetic PCI Outcomes

Presenter: David J. Maron, Steven P. Marso, Konstantinos Dean Boudoulas

September 22, 2018

Presentation TCT 2018

When is PCI a Valid Alternative To Only Medical Therapy or CABG in the Diabetic Patient?

Presenter: David J. Maron, Steven P. Marso, Sripal Bangalore

September 22, 2018

Presentation TCT 2018

Medical Therapy for Whom and When: What is the Ceiling of Medical Therapy?

Presenter: David J. Maron, Steven P. Marso, Norman E. Lepor

September 22, 2018

Presentation TCT 2018

Comprehensive CV Risk Reduction Strategy in Diabetics

Presenter: David J. Maron, Steven P. Marso, Kurt Huber

September 22, 2018

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Conference News ESC 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Michael O'Riordan

August 28, 2018

News Conference News ESC 2018

Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm

Todd Neale

August 27, 2018

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

News Conference News ESC 2018

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Michael O'Riordan

August 26, 2018

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Shelley Wood

August 25, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Daily News

Starting Low and Going Lower: Some Benefit to Very Low LDL Levels

Michael O'Riordan

August 02, 2018

News Daily News

Acute MI Rates on the Rise Among Pregnant Women in the US

Caitlin E. Cox

July 24, 2018

News Daily News

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Michael O'Riordan

July 19, 2018

News Daily News

Discharge Against Medical Advice After PCI Rare but Deadly

Michael O'Riordan

July 17, 2018

Advertisement

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

CHIP in The Diabetic Patient: Special Considerations

Complete Revascularization is the Missing Link to Improve Diabetic PCI Outcomes

When is PCI a Valid Alternative To Only Medical Therapy or CABG in the Diabetic Patient?

Medical Therapy for Whom and When: What is the Ceiling of Medical Therapy?

Comprehensive CV Risk Reduction Strategy in Diabetics

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

TCTMD’s Top 10 Most Popular Stories for August 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Starting Low and Going Lower: Some Benefit to Very Low LDL Levels

Acute MI Rates on the Rise Among Pregnant Women in the US

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Discharge Against Medical Advice After PCI Rare but Deadly

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content